Search

everythinglearnresearchcommunity

for

Search:↓

MARCKSL1 is important for wound healing and could be a target to reduce scarring.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

A new genetic region, 17q21.31, is linked to higher ovarian cancer risk.

IL-19 and IL-24 help cells respond to DNA damage and could be targeted for cancer and age-related disease treatments.

Measuring minimal residual disease on day 15 helps identify high-risk leukemia patients.

Panitumumab can cause excessive ear hair growth.

Four specific genes are linked to keloid formation and could be potential treatment targets.

The rs231775 genetic variant is linked to a higher risk and severity of Alopecia Areata in males.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.

Telocytes might help with skin repair and regeneration.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

ICL is a condition with low CD4+ T cells like AIDS but not caused by HIV, and normal CD4+ T cell counts may vary between men and women.

Cells with active Wnt signaling are less likely to turn into cancer when exposed to a cancer-causing gene.

RACB in barley is crucial for cell polarity and nucleus positioning, aiding fungal infection.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Tyrosinase and gp100 proteins can help diagnose and treat melanoma.

Blocking Rab27a slows hair growth, while blocking Rab27b encourages it.

Canine epidermal neural crest stem cells could be a promising treatment for spinal cord injuries in dogs.

Raman spectroscopy could effectively guide skin cancer surgery by identifying tumor margins.

Chemotherapy-induced hair loss is partly due to decreased laminin-511 and increased laminin-332.

Human thymus has stem cells that can self-renew and maintain their identity.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

The new antibody, TYHF-1, specifically targets certain hair-related structures.

Targeting colon cancer stem cells might lead to better treatment results.

TTNPB helps turn stem cells into neural stem cells, improving depression-like behaviors in rats.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

Patched1 helps prevent tumors by controlling cell growth.

The treatment improved survival and controlled cancer spread but required managing side effects like rashes.

Notch signaling stops Merkel cell development, and hair follicles help maintain them after skin injury.